scientifyRESEARCH
research funding database

RESEARCH FUNDING

Transformative Breast Cancer Consortium Award (worldwide)

Share this post

Logo of scientifyRESEARCH and Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.
Logo of scientifyRESEARCH + logo of Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.

The Transformative Breast Cancer Consortium Development Award from the Congressionally Directed Medical Research Programs (CDMRP) supports collaborations and ideas that will transform the lives of individuals with, and/or at risk for, breast cancer and will significantly accelerate progress toward ending breast cancer. Applicants must bring together different perspectives to develop new paradigms that will solve fundamental yet overarching problems in breast cancer. This award requires a team-based approach by a consortium of exceptional researchers and advocates, whose collaborative efforts will make a transformative impact in breast cancer. The transformation intended by the consortium must be in people’s lives, and not in the healthcare or research system. The program is open to researchers in the USA and worldwide.

The award provides up to 25 million USD over 4 years. Indirect costs may be covered.

Funding Opportunity Number: HT942524BCRPTBCCA

Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), May 14, 2024. Application Submission Deadline: 11:59 p.m. ET, August 6, 2024.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for our monthly
research funding newsletter

you can unsubscribe at any time

Be the first to know

Sign-up for Personalized Grant Alerts

Logo3